Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TEVA
TEVA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TEVA News
HHS Considers Restrictions on Antidepressant Use Amid Mental Health Crisis
1d ago
seekingalpha
Teva Pharmaceuticals to Present at BofA Healthcare Conference
5d ago
Newsfilter
TEVA PHARMACEUTICALS: UBS Increases Price Target from $36 to $42
May 01 2026
moomoo
Latest Developments in the Biotech Sector
Apr 30 2026
NASDAQ.COM
Teva Exceeds All Sustainability Bond Targets
Apr 30 2026
Newsfilter
Teva Acquires Emalex to Boost Growth Strategy
Apr 30 2026
Yahoo Finance
Blackstone's $400 Million Investment in Teva: A Strategic Bet
Apr 30 2026
Fool
Blackstone Commits $400 Million to Teva's Drug Development
Apr 30 2026
NASDAQ.COM
DBEF ETF 52-Week Price Analysis
Apr 29 2026
NASDAQ.COM
Teva Pharmaceutical Adjusts Outlook Despite Strong Q1 Performance
Apr 29 2026
seekingalpha
Teva Stock Rises on Strong Q1 Performance as Key Brands Outperform Generics
Apr 29 2026
Yahoo Finance
Teva Pharmaceutical Exceeds Q1 Forecasts but Lowers Full-Year Outlook
Apr 29 2026
seekingalpha
Teva Pharmaceutical Q1 Earnings Beat Expectations
Apr 29 2026
seekingalpha
Teva Pharmaceutical Q1 Earnings Announcement Scheduled
Apr 28 2026
seekingalpha
Teva Pharmaceutical Faces Revenue and Profitability Declines Ahead of Q1 Results
Apr 28 2026
NASDAQ.COM
Teva Pharmaceutical's Q1 Results Preview and Strategic Growth Insights
Apr 28 2026
Fool
Show More News
